Literature DB >> 23494606

Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein.

Takeshi Soeki1, Toshiyuki Niki, Etsuko Uematsu, Sachiko Bando, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Yuka Ueda, Noriko Tomita, Koji Yamaguchi, Kunihiko Koshiba, Shusuke Yagi, Daiju Fukuda, Yoshio Taketani, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Masashi Akaike, Michio Shimabukuro, Ichiro Kishimoto, Kenji Kangawa, Masataka Sata.   

Abstract

Vagal nerve stimulation has been postulated to confer an antifibrillatory effect. We studied whether ghrelin administration would exert an antiarrhythmic effect via modulation of autonomic nerve activity in rats after acute myocardial ischemia (MI). Male Sprague-Dawley rats were exposed to 30 min of ischemia following ligation of the left coronary artery. Animals were then randomized to receive either ghrelin (n = 26) or saline (n = 26) during the period of coronary ligation. Power spectral analysis of heart-rate variability revealed that the administration of ghrelin increased the high-frequency (HF) power and decreased the low-frequency (LF)/HF ratio. Ventricular tachyarrhythmias were less frequent in rats after MI who received ghrelin in comparison with rats that received saline. Immunoblotting and immunohistochemistry revealed that rats given saline alone during MI exhibited a marked reduction in phosphorylated connexin-43 within the left ventricle, whereas those that received ghrelin displayed only minor reductions in comparison with sham-operated rats. These effects of ghrelin were diminished by the coadministration of atropine or the blockade of vagal afferents. These data demonstrate that the beneficial effect of ghrelin might be mediated by modulation of cardiac autonomic nerve activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494606     DOI: 10.1007/s00380-013-0333-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  26 in total

Review 1.  Regulation of muscarinic acetylcholine receptor signaling.

Authors:  Chris J van Koppen; Björn Kaiser
Journal:  Pharmacol Ther       Date:  2003-05       Impact factor: 12.310

2.  Central ghrelin modulates sympathetic activity in conscious rabbits.

Authors:  Kiyoshi Matsumura; Takuya Tsuchihashi; Koji Fujii; Isao Abe; Mitsuo Iida
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

Review 3.  Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure.

Authors:  Noritoshi Nagaya; Kenji Kangawa
Journal:  Curr Opin Pharmacol       Date:  2003-04       Impact factor: 5.547

4.  Role of nitric oxide and protein kinase C in ACh-induced cardioprotection.

Authors:  H Liu; B C McPherson; X Zhu; M L Da Costa; V Jeevanandam; Z Yao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-07       Impact factor: 4.733

5.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction.

Authors:  E Vanoli; G M De Ferrari; M Stramba-Badiale; S S Hull; R D Foreman; P J Schwartz
Journal:  Circ Res       Date:  1991-05       Impact factor: 17.367

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats.

Authors:  Meihua Li; Can Zheng; Takayuki Sato; Toru Kawada; Masaru Sugimachi; Kenji Sunagawa
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

8.  Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia.

Authors:  Wilhelm Roell; Thorsten Lewalter; Philipp Sasse; Yvonne N Tallini; Bum-Rak Choi; Martin Breitbach; Robert Doran; Ulrich M Becher; Seong-Min Hwang; Toktam Bostani; Julia von Maltzahn; Andreas Hofmann; Shaun Reining; Britta Eiberger; Bethann Gabris; Alexander Pfeifer; Armin Welz; Klaus Willecke; Guy Salama; Jan W Schrickel; Michael I Kotlikoff; Bernd K Fleischmann
Journal:  Nature       Date:  2007-12-06       Impact factor: 49.962

9.  Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality.

Authors:  Daryl O Schwenke; Takeshi Tokudome; Ichiro Kishimoto; Takeshi Horio; Mikiyasu Shirai; Patricia A Cragg; Kenji Kangawa
Journal:  Endocrinology       Date:  2008-07-03       Impact factor: 4.736

10.  Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

Authors:  Gianluca Baldanzi; Nicoletta Filigheddu; Santina Cutrupi; Filomena Catapano; Sara Bonissoni; Alberto Fubini; Daniela Malan; Germano Baj; Riccarda Granata; Fabio Broglio; Mauro Papotti; Nicola Surico; Federico Bussolino; Jorgen Isgaard; Romano Deghenghi; Fabiola Sinigaglia; Maria Prat; Giampiero Muccioli; Ezio Ghigo; Andrea Graziani
Journal:  J Cell Biol       Date:  2002-12-16       Impact factor: 10.539

View more
  9 in total

Review 1.  Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.

Authors:  Rasha Mofeed Habeeb Mosa; Zhen Zhang; Renfu Shao; Chao Deng; Jiezhong Chen; Chen Chen
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

Review 2.  Dysregulation of Mfn2 and Drp-1 proteins in heart failure.

Authors:  Srikanth Givvimani; Sathnur Pushpakumar; Sudhakar Veeranki; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2014-05-09       Impact factor: 2.273

3.  Pentraxin 3 is a local inflammatory marker in atrial fibrillation.

Authors:  Takeshi Soeki; Sachiko Bando; Etsuko Uematsu; Tomomi Matsuura; Toshiyuki Niki; Takayuki Ise; Kenya Kusunose; Junko Hotchi; Yuka Ueda; Noriko Tomita; Koji Yamaguchi; Shusuke Yagi; Daiju Fukuda; Yoshio Taketani; Takashi Iwase; Hirotsugu Yamada; Tetsuzo Wakatsuki; Michio Shimabukuro; Masataka Sata
Journal:  Heart Vessels       Date:  2013-08-27       Impact factor: 2.037

Review 4.  Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments.

Authors:  Anais Audebrand; Laurent Désaubry; Canan G Nebigil
Journal:  Front Cardiovasc Med       Date:  2020-01-24

Review 5.  Physiological significance of ghrelin in the cardiovascular system.

Authors:  Takeshi Tokudome; Kenji Kangawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2019       Impact factor: 3.493

Review 6.  Research progress of ghrelin on cardiovascular disease.

Authors:  Ming-Jie Yuan; Wei Li; Peng Zhong
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

7.  Effect of sleeve gastrectomy, Roux-en-Y gastric bypass, and ileal transposition on myocardial ischaemia-reperfusion injury in non-obese non-diabetic rats.

Authors:  Oleg Kornyushin; Dmitry Sonin; Alexander Polozov; Vitaly Masley; Nika Bulavinova; Maria Chervyak; Maria Istomina; Daria Mukhametdinova; Alexander Neimark; Yuri Cheburkin; Yana Toropova; Kira Derkach; Alexander Shpakov; Michael Galagudza; Evgenyi Shlyakhto
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

Review 8.  Effect of Ghrelin on the Cardiovascular System.

Authors:  Hiroshi Hosoda
Journal:  Biology (Basel)       Date:  2022-08-08

Review 9.  The controversial role of the vagus nerve in mediating ghrelin's actions: gut feelings and beyond.

Authors:  Mario Perelló; María P Cornejo; Pablo N De Francesco; Gimena Fernandez; Laurent Gautron; Lesly S Valdivia
Journal:  IBRO Neurosci Rep       Date:  2022-03-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.